Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Achieving Optimal Medical Therapy Through Percutaneous Treatment of Secondary Mitral Regurgitation to Improve Outcome in Patients With HFrEF

NCT07758023 is registered in ClinicalTrials.gov with University Medical Center Mainz as lead sponsor.

NCT NCT07758023
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07758023 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Achieving Optimal Medical Therapy Through Percutaneous Treatment of Secondary Mitral Regurgitation to Improve Outcome in Patients With HFrEF
Lead sponsor
University Medical Center Mainz
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 10, 2026
Completion date
September 30, 2030
Enrollment
520 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with reduced ejection fraction (hfref), mitral regurgitation functional